Leader in the health sector in Bulgaria with a strong market position

“Sopharma” AD realizes its social role on the local market and uses its financial stability for the benefit of the society.

OUR POSITION

Sopharma is a market leader in units with 11% market share and number 8 in value of sales with 3%.

MARKET SHARE IN BULGARIA*

* Data from IQVIA

RECOGNISED TRADE MARKS

Two of the generic products of “Sopharma” AD are among of top 10 best-selling products in Bulgaria. This leading position is mainly attributed to excellent brand recognition (Analgin, Vitamin C).

Product	Class	Therapeutic group
Carsil^тм	Developed within the Company	Digestive system and metabolism
Tabex^тм	Developed within the Company	Smoking cessation
Tempalgin^тм	Formulation developed within the Company	Pain relief, cold and flue
Analgin^тм	Branded generic	Pain relief, cold and flue
Nivalin^тм	Developed within the Company	Nervous system

Competitive pricing

Affordable treatment with European quality - our products are produced in modern facilities meeting all the quality requirements and are GMP certified.

MARKET SHARE IN BULGARIA IN VALUE*

* Data from IQVIA

LEADER IN BULGARIA